Exhibit 10.19
November 8, 2022
Shahram Salek-Ardakani, Ph.D.
Re: Transition and Consulting Agreement
Dear Shahram:
This letter sets forth the substance of the transition and consulting agreement (the “Agreement”) that Janux Therapeutics, Inc. (the “Company”) is offering to you to aid in your employment transition.
277163320 v3
Page 2
277163320 v3
Page 3
277163320 v3
Page 4
277163320 v3
Page 5
277163320 v3
Page 6
“A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party.”
You hereby expressly waive and relinquish all rights and benefits under that section and any law of any other jurisdiction of similar effect with respect to your release of claims herein, including but not limited to your release of unknown claims.
277163320 v3
Page 7
277163320 v3
Page 8
277163320 v3
Page 9
If this Agreement is acceptable to you, please sign below and return the original to me within the timeline provided in this Agreement, otherwise the Company’s offer contained herein will automatically expire.
We wish you the best in your future endeavors.
Sincerely,
Janux Therapeutics, Inc.
By: /s/ David Campbell
David Campbell, Ph.D.
President and Chief Executive Officer
Exhibit A – Confidential Information and Inventions Assignment Agreement
I have read, understand and agree fully to the foregoing Agreement:
/s/ Shahram Salek-Ardakani
Shahram Salek-Ardakani, Ph.D.
November 10, 2022
Date
277163320 v3